Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber

Status:
Completed

Trial end date:
2010-04-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the safety and effect of CAL-263 in subjects with allergic rhinitis.

Phase 1

Gilead Sciences